SCHEMBL13870838

SCHEMBL13870838

O=C(Nc1ccccc1C(=O)O)c1cccc(NC(=O)c2ccco2)c1

nearest known ligand 0.81

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.81
▸ GAA P10253 2/20 0.81
▸ KMT2A Q03164 8/20 0.71
▸ MEN1 O00255 7/20 0.71
▸ SIRT6 Q8N6T7 1/20 0.71
▸ SIRT3 Q9NTG7 1/20 0.71
▸ KCNK3 O14649 2/20 0.70
▸ KCNK9 Q9NPC2 2/20 0.70
▸ POLB P06746 3/20 0.67
▸ RAB9A P51151 2/20 0.67
▸ BLM P54132 1/20 0.67
▸ LMNA P02545 3/20 0.65
▸ TSHR P16473 1/20 0.65
▸ MAPK1 P28482 1/20 0.63
▸ PKM P14618 1/20 0.63
▸ MAPT P10636 2/20 0.62
▸ RXFP1 Q9HBX9 1/20 0.62
▸ ADRB2 P07550 1/20 0.62
▸ KDM4E B2RXH2 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3503699 0.90 GAA (1.00) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL13870855 0.88 MEN1 (0.72) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL6348632 0.86 MEN1 (0.69) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL14855642 0.86 KMT2A (0.79) ALDH1A1GAAKMT2AMEN1KCNK3
SCHEMBL15528812 0.86 MAPK1 (0.71) ALDH1A1GAAKMT2AMEN1POLB
SCHEMBL16179842 0.83 KMT2A (0.83) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL16179714 0.83 MEN1 (1.00) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL29564094 0.83 MEN1 (1.00) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL18906020 0.83 RAB9A (0.79) ALDH1A1GAAKMT2AMEN1SIRT6
SCHEMBL13870842 0.81 KMT2A (0.67) ALDH1A1GAAKMT2AMEN1KCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105218-A1 CRTH2 Receptor Ligands For Therapeutic Use 7TM PHARMA A/S (DK) 2009-04-23 — — US disclosed
US-20090105218-A1 CRTH2 Receptor Ligands For Therapeutic Use 7TM PHARMA A/S (DK) 2009-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105218-A1 CRTH2 Receptor Ligands For Therapeutic Use NR1H2, NR1H3, HRH2 ALDH1A1 787/4885GAA 4471/4885KMT2A 2570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback